Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?

Atherosclerosis. 2003 Feb;166(2):413-4. doi: 10.1016/s0021-9150(02)00378-7.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Blood Chemical Analysis
  • Cholesterol, HDL / analysis
  • Cholesterol, HDL / drug effects
  • Cholesterol, LDL / analysis
  • Cholesterol, LDL / drug effects
  • Combined Modality Therapy
  • Diet Therapy / methods*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Humans
  • Hypercholesterolemia / diagnosis
  • Hypercholesterolemia / diet therapy*
  • Hypercholesterolemia / drug therapy*
  • Japan
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Pravastatin / therapeutic use*
  • Probability
  • Prospective Studies
  • Receptors, Tumor Necrosis Factor / analysis*
  • Receptors, Tumor Necrosis Factor / drug effects*
  • Regression Analysis
  • Solubility
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Receptors, Tumor Necrosis Factor
  • Pravastatin